[开放获取]    白癜风光疗指南（2025版）

doi:10.35541/cjd.20240547

Abstract

Abstract: 【Abstract】 Ultraviolet phototherapy stands as a pivotal intervention in the management of vitiligo. To guide and standardize the application of ultraviolet phototherapy in the treatment of vitiligo, and to improve its efficacy and safety, the Dermatology Professional Committee of Chinese Research Hospital Society and the China Dermatologist Association organized Chinese experts in the fields of photomedicine and pigmentary disorders to formulate the “Guideline on phototherapy for vitiligo （2025 edition）” after thorough discussions based on the latest research progress in vitiligo phototherapy in China and other countries in recent years and the clinical experience of experts. This guideline comprehensively delineates core clinical considerations pertaining to phototherapy for vitiligo, including the therapeutic principles, contraindications, individualized phototherapy protocols, strategies for combination therapies, and management of adverse reactions, aiming to further improve the performance of phototherapy in the treatment of vitiligo in China.

Key words: Vitiligo, Phototherapy, Ultraviolet therapy, Therapeutics, Guideline

Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Guideline on phototherapy for vitiligo （2025 edition）[J]. Chinese Journal of Dermatology, 2025, 58(3): 197-208.doi:10.35541/cjd.20240547

References ［114］

［1］	Bergqvist C, Ezzedine K. Vitiligo: a focus on pathogenesis and its therapeutic implications［J］. J Dermatol, 2021,48（3）:252⁃270. doi: 10.1111/1346⁃8138.15743.
［2］	Bae JM, Jung HM, Hong BY, et al. Phototherapy for vitiligo: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2017,153（7）:666⁃674. doi: 10.1001/jamadermatol.2017.0002.
［3］	康德英, 许能锋. 循证医学［M］. 3版. 北京: 人民卫生出版社, 2015:51⁃52.
［4］	Li Y, Zhang RZ. Mobilization of melanocytes during NB⁃UVB treatment of vitiligo［J］. Int J Dermatol Venereol, 2021,4（3）:163⁃167. doi: 10.1097/JD9.0000000000000128.
［5］	Vieyra⁃Garcia PA, Wolf P. A deep dive into UV⁃based phototherapy: mechanisms of action and emerging molecular targets in inflammation and cancer［J］. Pharmacol Ther, 2021,222:107784. doi: 10.1016/j.pharmthera.2020.107784.
［6］	Yamada T, Hasegawa S, Inoue Y, et al. Wnt/β⁃catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB⁃induced epidermal pigmentation［J］. J Invest Dermatol, 2013,133（12）:2753⁃2762. doi: 10.1038/jid. 2013.235.
［7］	Tembhre MK, Sharma VK, Sharma A, et al. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo［J］. Clin Chim Acta, 2013,424:27⁃32. doi: 10.1016/j.cca.2013.05.005.
［8］	Wu CS, Yu CL, Wu CS, et al. Narrow⁃band ultraviolet⁃B stimulates proliferation and migration of cultured melanocytes［J］. Exp Dermatol, 2004,13（12）:755⁃763. doi: 10.1111/j.0906⁃6705.2004.00221.x.
［9］	Moretti S, Fabbri P, Baroni G, et al. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis［J］. Histol Histopathol, 2009,24（7）:849⁃857. doi: 10.14670/HH⁃24.849.
［10］	Sharma CK, Sharma M, Prasad K. Involvement of different genes expressions during immunological and inflammatory responses in vitiligo［J］. Crit Rev Eukaryot Gene Expr, 2017,27（3）:277⁃287. doi: 10.1615/CritRevEukaryotGeneExpr.2017019558.
［11］	Jung EG. The red face: photogenodermatoses［J］. Clin Dermatol, 1993,11（2）:275⁃281. doi: 10.1016/0738⁃081x（93）90063⁃i.
［12］	Goulden V, Ling TC, Babakinejad P, et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022［J］. Br J Dermatol, 2022,187（3）:295⁃308. doi: 10.1111/bjd.21669.
［13］	中国医师协会皮肤科医师分会规范化诊疗工作委员会, 中国医学装备协会皮肤病与皮肤美容专业委员会皮肤外科装备学组和皮肤光治疗学组. 窄谱中波紫外线家庭光疗临床应用专家共识［J］. 中华皮肤科杂志, 2019,52（3）:156⁃161. doi: 10.3760/cma.j.issn.0412⁃4030.2019.03.002.
［14］	Dahir AM, Thomsen SF. Comorbidities in vitiligo: comprehensive review［J］. Int J Dermatol, 2018,57（10）:1157⁃1164. doi: 10.1111/ ijd.14055.
［15］	Lee JH, Ju HJ, Seo JM, et al. Comorbidities in patients with vitiligo: a systematic review and meta⁃analysis［J］. J Invest Dermatol, 2023,143（5）:777⁃789.e6. doi: 10.1016/j.jid.2022.10. 021.
［16］	Premkumar M, Kalarani IB, Mohammed V, et al. An extensive review of vitiligo⁃associated conditions［J］. Int J Dermatol Venerol, 2024,7（1）:44⁃51. doi: 10.1097/JD9.0000000000000346.
［17］	Esmat SM, El⁃Mofty M, Rasheed H, et al. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo⁃types （III⁃V）: a double⁃blind, randomized, placebo⁃controlled, prospective, multicenter study［J］. Photodermatol Photoimmunol Photomed, 2022,38（3）:277⁃287. doi: 10.1111/phpp.12749.
［18］	Kanwar AJ, Dogra S, Parsad D, et al. Narrow⁃band UVB for the treatment of vitiligo: an emerging effective and well⁃tolerated therapy［J］. Int J Dermatol, 2005,44（1）:57⁃60. doi: 10.1111/j.1365⁃4632.2004.02329.x.
［19］	Bhatnagar A, Kanwar AJ, Parsad D, et al. Psoralen and ultraviolet A and narrow⁃band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study［J］. J Eur Acad Dermatol Venereol, 2007,21（10）:1381⁃1385. doi: 10.1111/j.1468⁃3083.2007.02283.x.
［20］	Majid I, Imran S. Excimer light therapy in childhood segmental vitiligo: early treatment gives better results［J］. Dermatol Ther, 2020,33（3）:e13408. doi: 10.1111/dth.13408.
［21］	Do JE, Shin JY, Kim DY, et al. The effect of 308 nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo［J］. Photodermatol Photoimmunol Photomed, 2011,27（3）:147⁃151. doi: 10.1111/j.1600⁃0781.2011.00587.x.
［22］	Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference［J］. Pigment Cell Melanoma Res, 2012,25（3）:E1⁃13. doi: 10.1111/j.1755⁃148X.2012.00997.x.
［23］	中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识（2021版）［J］. 中华皮肤科杂志, 2021,54（2）:105⁃109. doi: 10.35541/cjd.20200785.
［24］	Lommerts JE, Uitentuis SE, Bekkenk MW, et al. The role of phototherapy in the surgical treatment of vitiligo: a systematic review［J］. J Eur Acad Dermatol Venereol, 2018,32（9）:1427⁃1435. doi: 10.1111/jdv.14950.
［25］	Choi KH, Park JH, Ro YS. Treatment of vitiligo with 308⁃nm xenon⁃chloride excimer laser: therapeutic efficacy of different initial doses according to treatment areas［J］. J Dermatol, 2004,31（4）:284⁃292. doi: 10.1111/j.1346⁃8138.2004.tb00674.x.
［26］	Alhowaish AK, Dietrich N, Onder M, et al. Effectiveness of a 308⁃nm excimer laser in treatment of vitiligo: a review［J］. Lasers Med Sci, 2013,28（3）:1035⁃1041. doi: 10.1007/s10103⁃012⁃1185⁃1.
［27］	Bae JM, Hann SK. Laser treatments for vitiligo［J］. Med Lasers, 2016,5（2）:63⁃70. doi:10.25289/ML.2016.5. 2.63.
［28］	Mohammad TF, Al⁃Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo［J］. J Am Acad Dermatol, 2017,76（5）:879⁃888. doi: 10.1016/j.jaad.2016.12.041.
［29］	Hofer A, Hassan AS, Legat FJ, et al. Optimal weekly frequency of 308⁃nm excimer laser treatment in vitiligo patients［J］. Br J Dermatol, 2005,152（5）:981⁃985. doi: 10.1111/j.1365⁃2133.2004. 06321.x.
［30］	Seneschal J, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the international Vitiligo Task Force⁃Part 2: specific treatment recommendations［J］. J Eur Acad Dermatol Venereol, 2023,37（11）:2185⁃2195. doi: 10.1111/jdv. 19450.
［31］	Nicolaidou E, Antoniou C, Stratigos AJ, et al. Efficacy, predictors of response, and long⁃term follow⁃up in patients with vitiligo treated with narrowband UVB phototherapy［J］. J Am Acad Dermatol, 2007,56（2）:274⁃278. doi: 10.1016/j.jaad.2006. 09.004.
［32］	Errichetti E, Zelin E, Pinzani C, et al. Dermoscopic and clinical response predictor factors in nonsegmental vitiligo treated with narrowband ultraviolet B phototherapy: a prospective observational study［J］. Dermatol Ther （Heidelb）, 2020,10（5）:1089⁃1098. doi: 10.1007/s13555⁃020⁃00431⁃6.
［33］	van Geel N, Speeckaert R, De Wolf J, et al. Clinical significance of Koebner phenomenon in vitiligo［J］. Br J Dermatol, 2012,167（5）:1017⁃1024. doi: 10.1111/j.1365⁃2133.2012.11158.x.
［34］	Hojman L, Cabrera R, Karsulovic C, et al. The role of CXCL10 and IL⁃18 as markers of repigmentation response in nonsegmental vitiligo treated with narrowband UVB phototherapy: a prospective Cohort study［J］. J Invest Dermatol, 2021,141（7）:1833⁃1836.e1. doi: 10.1016/j.jid.2020.12.021.
［35］	Parihar AS, Tembhre MK, Sharma VK, et al. Effect of narrowband ultraviolet B treatment on microRNA expression in active nonsegmental generalized vitiligo［J］. Br J Dermatol, 2020,183（1）:167⁃169. doi: 10.1111/bjd.18890.
［36］	Monib K, Sabry HH, Hussein MS, et al. Factors affecting vitiligo response to treatment: do MiRNA 196a2C/T gene polymorphism and serum tyrosinase levels have any role?［J］. J Dermatolog Treat, 2022,33（3）:1351⁃1355. doi: 10.1080/09546634.2020.181 0202.
［37］	Lin F, Sun X, Lei J, et al. Altered circulating memory T cells in vitiligo cases followed NB⁃UVB therapy［J］. Photodermatol Photoimmunol Photomed, 2022,38（1）:76⁃82. doi: 10.1111/phpp. 12719.
［38］	Salem RM, Abdelrahman A, Abd El⁃Kareem HM, et al. DEFB1 gene polymorphisms modify vitiligo extent and response to NB⁃UVB phototherapy［J］. Dermatol Ther, 2021,34（3）:e14921. doi: 10.1111/dth.14921.
［39］	Monib K, Sorour NE, Alhusseini NF, et al. Could α MSH⁃MIFT axis and IDH2 be considered promising predictors of non⁃segmental vitiligo response to NB⁃UVB phototherapy?［J］. J Clin Aesthet Dermatol, 2023,16（1）:41⁃46.
［40］	Parsad D, Pandhi R, Dogra S, et al. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches［J］. J Am Acad Dermatol, 2004,50（1）:63⁃67. doi: 10.1016/s0190⁃9622（03）00786⁃2.
［41］	Lei TC, Hearing VJ. Deciphering skin re⁃pigmentation patterns in vitiligo: an update on the cellular and molecular events involved［J］. Chin Med J （Engl）, 2020,133（10）:1231⁃1238. doi: 10.1097/CM9.0000000000000794.
［42］	Silpa⁃Archa N, Weerasubpong P, Junsuwan N, et al. Treatment outcome and persistence of repigmentation from narrow⁃band ultraviolet B phototherapy in vitiligo［J］. J Dermatolog Treat, 2019,30（7）:691⁃696. doi: 10.1080/09546634.2018.1544409.
［43］	贺楷乔, 李舒丽, 李柏樟, 等. 白癜风光疗复色模式的临床观察及其影响因素分析［J］. 中华皮肤科杂志, 2024,57（1）:23⁃28. doi:10.35541/cjd.20230367.
［44］	Lopes C, Trevisani VF, Melnik T. Efficacy and safety of 308⁃nm monochromatic excimer lamp versus other phototherapy devices for vitiligo: a systematic review with meta⁃analysis［J］. Am J Clin Dermatol, 2016,17（1）:23⁃32. doi: 10.1007/s40257⁃015⁃0164⁃2.
［45］	Tabassum H, Majid I, Imran S. Is targeted UVB as effective as excimer light phototherapy in treatment of vitiligo?［J］. Dermatol Ther, 2021,34（5）:e15058. doi: 10.1111/dth.15058.
［46］	Poolsuwan P, Churee C, Pattamadilok B. Comparative efficacy between localized 308⁃nm excimer light and targeted 311⁃nm narrowband ultraviolet B phototherapy in vitiligo: a randomized, single⁃blind comparison study［J］. Photodermatol Photoimmunol Photomed, 2021,37（2）:123⁃130. doi: 10.1111/phpp.12619.
［47］	Yadav D, Khandpur S, Bhari N. Targeted phototherapy with excimer light is not efficacious in the management of residual vitiligo patches following whole⁃body narrowband ultraviolet B light therapy: results of a retrospective case series［J］. Indian J Dermatol Venereol Leprol, 2022,88（2）:249⁃251. doi: 10.25259/IJDVL_8_2020.
［48］	Le Duff F, Fontas E, Giacchero D, et al. 308⁃nm excimer lamp vs. 308⁃nm excimer laser for treating vitiligo: a randomized study［J］. Br J Dermatol, 2010,163（1）:188⁃192. doi: 10.1111/j.1365⁃2133.2010.09778.x.
［49］	Hu Y, Liu L, Xu Z, et al. Comparing the efficacy of 308⁃nm light⁃emitting diode and 308⁃nm excimer lamp for treating vitiligo: a randomized controlled trial［J］. Photodermatol Photoimmunol Photomed, 2024,40（3）:e12972. doi: 10.1111/phpp.12972.
［50］	Luan C, Hu Y, Ju M, et al. Treatment of vitiligo with 308⁃nm light emitting diode: our experience from a two⁃year follow⁃up of Chinese patients［J］. Photodermatol Photoimmunol Photomed, 2022,38（5）:489⁃494. doi: 10.1111/phpp.12777.
［51］	Teasdale E, Muller I, Abdullah Sani A, et al. Views and experiences of seeking information and help for vitiligo: a qualitative study of written accounts［J］. BMJ Open, 2018,8（1）:e018652. doi: 10.1136/bmjopen⁃2017⁃018652.
［52］	Tien Guan ST, Theng C, Chang A. Randomized, parallel group trial comparing home⁃based phototherapy with institution⁃based 308 excimer lamp for the treatment of focal vitiligo vulgaris［J］. J Am Acad Dermatol, 2015,72（4）:733⁃735. doi: 10.1016/j.jaad. 2014.12.026.
［53］	Liu B, Sun Y, Song J, et al. Home vs hospital narrowband UVB treatment by a hand⁃held unit for new⁃onset vitiligo: a pilot randomized controlled study［J］. Photodermatol Photoimmunol Photomed, 2020,36（1）:14⁃20. doi: 10.1111/phpp.12495.
［54］	DePry J, Brescoll J, Szczotka⁃Flynn L, et al. Phototherapy⁃related ophthalmologic disorders［J］. Clin Dermatol, 2015,33（2）:247⁃255. doi: 10.1016/j.clindermatol.2014.10.017.
［55］	Prystowsky JH, Keen MS, Rabinowitz AD, et al. Present status of eyelid phototherapy. Clinical efficacy and transmittance of ultraviolet and visible radiation through human eyelids［J］. J Am Acad Dermatol, 1992,26（4）:607⁃613. doi: 10.1016/0190⁃9622（92）70089⁃x.
［56］	Giblin FJ, Lin LR, Leverenz VR, et al. A class I （Senofilcon A） soft contact lens prevents UVB⁃induced ocular effects, including cataract, in the rabbit in vivo［J］. Invest Ophthalmol Vis Sci, 2011,52（6）:3667⁃3675. doi: 10.1167/iovs.10⁃6885.
［57］	Giblin FJ, Lin LR, Simpanya MF, et al. A class I UV⁃blocking （senofilcon A） soft contact lens prevents UVA⁃induced yellow fluorescence and NADH loss in the rabbit lens nucleus in vivo［J］. Exp Eye Res, 2012,102:17⁃27. doi: 10.1016/j.exer.2012.06. 007.
［58］	Stern RS, Bagheri S, Nichols K, et al. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A （PUVA） for psoriasis［J］. J Am Acad Dermatol, 2002,47（1）:33⁃39. doi: 10.1067/mjd.2002.124618.
［59］	Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation （PUVA） and ultraviolet B radiation. The photochemotherapy follow⁃up study［J］. N Engl J Med, 1990,322（16）:1093⁃1097. doi: 10.1056/NEJM199004193 221601.
［60］	Deshpande AJ. 308 nm excimer lamp monotherapy for lip vitiligo⁃a short case series［J］. J Cosmet Laser Ther, 2020,22（6⁃8）:253⁃255. doi: 10.1080/14764172.2021.1936065.
［61］	Cho S, Zheng Z, Park YK, et al. The 308⁃nm excimer laser: a promising device for the treatment of childhood vitiligo［J］. Photodermatol Photoimmunol Photomed, 2011,27（1）:24⁃29. doi: 10.1111/j.1600⁃0781.2010.00558.x.
［62］	Ersoy⁃Evans S, Altaykan A, Sahin S, et al. Phototherapy in childhood［J］. Pediatr Dermatol, 2008,25（6）:599⁃605. doi: 10.1111/j.1525⁃1470.2008.00773.x.
［63］	Eustace K, Dolman S, Alsharqi A, et al. Use of phototherapy in children［J］. Pediatr Dermatol, 2017,34（2）:150⁃155. doi: 10. 1111/pde.13072.
［64］	Bangsgaard N, Rørbye C, Skov L. Treating psoriasis during pregnancy: safety and efficacy of treatments［J］. Am J Clin Dermatol, 2015,16（5）:389⁃398. doi: 10.1007/s40257⁃015⁃0137⁃5.
［65］	AlJasser MI. Dermoscopy for facial leukotrichia in vitiligo: an important step for a better treatment decision［J］. Dermatol Pract Concept, 2022,12（3）:e2022114. doi: 10.5826/dpc.1203a114.
［66］	Mogawer RM, Elmasry MF, Mostafa WZ. New insights into leukotrichia in nonsegmental vitiligo: a cross⁃sectional study［J］. Indian J Dermatol Venereol Leprol, 2019,85（4）:374⁃379. doi: 10.4103/ijdvl.IJDVL_49_18.
［67］	Lee DY, Kim CR, Park JH, et al. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment［J］. Int J Dermatol, 2011,50（8）:925⁃927. doi: 10. 1111/j.1365⁃4632.2011.04914.x.
［68］	Lei N, Cao X, Feng Y, et al. A novel reverse perilesional home phototherapy can promote the repigmentation of vitiligo patches with complete leukotrichia: a 12⁃week, open⁃label, double⁃arm, multicenter, randomized clinical trial［J］. Photodermatol Photoimmunol Photomed, 2024,40（3）:e12974. doi: 10.1111/phpp.12974.
［69］	Zhu B, Liu C, Zhang L, et al. Comparison of NB⁃UVB combination therapy regimens for vitiligo: a systematic review and network meta⁃analysis［J］. J Cosmet Dermatol, 2023,22（3）:1083⁃1098. doi: 10.1111/jocd.15534.
［70］	Li R, Qiao M, Wang X, et al. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta⁃analysis［J］. Photodermatol Photoimmunol Photomed, 2017,33（1）:22⁃31. doi: 10.1111/phpp.12277.
［71］	Lee J, Chu H, Lee H, et al. A retrospective study of methylprednisolone mini⁃pulse therapy combined with narrow⁃band UVB in non⁃segmental vitiligo［J］. Dermatology, 2016,232（2）:224⁃229. doi: 10.1159/000439563.
［72］	Thomas KS, Batchelor JM, Akram P, et al. Randomized controlled trial of topical corticosteroid and home⁃based narrowband ultraviolet B for active and limited vitiligo: results of the HI⁃Light Vitiligo Trial［J］. Br J Dermatol, 2021,184（5）:828⁃839. doi: 10.1111/bjd.19592.
［73］	Fang WC, Lin SY, Huang SM, et al. Low⁃dose tofacitinib with 308⁃nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo［J］. Clin Exp Dermatol, 2022,47（4）:782⁃783. doi: 10.1111/ced.15070.
［74］	Song H, Hu Z, Zhang S, et al. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real⁃world clinical practice［J］. Dermatol Ther, 2022,35（11）:e15821. doi: 10.1111/dth.15821.
［75］	Liu LY, Strassner JP, Refat MA, et al. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure［J］. J Am Acad Dermatol, 2017,77（4）:675⁃682.e1. doi: 10.1016/j.jaad.2017.05.043.
［76］	Xu Z, Xuan Y, Li Y, et al. A prospective observational study of oral abrocitinib and narrow⁃band ultraviolet⁃B in refractory progressive vitiligo［J］. J Am Acad Dermatol, 2024,91（3）:590⁃592. doi: 10.1016/j.jaad.2024.05.078.
［77］	Sheikh A, Rafique W, Owais R, et al. FDA approves ruxolitinib （Opzelura） for vitiligo therapy: a breakthrough in the field of dermatology［J］. Ann Med Surg （Lond）, 2022,81:104499. doi: 10.1016/j.amsu.2022.104499.
［78］	Pandya AG, Harris JE, Lebwohl M, et al. Addition of narrow⁃band UVB phototherapy to ruxolitinib cream in patients with vitiligo［J］. J Invest Dermatol, 2022,142（12）:3352⁃3355.e4. doi: 10.1016/j.jid.2022.05.1093.
［79］	Phan K, Phan S, Shumack S, et al. Repigmentation in vitiligo using janus kinase （JAK） inhibitors with phototherapy: systematic review and meta⁃analysis［J］. J Dermatolog Treat, 2022,33（1）:173⁃177. doi: 10.1080/09546634.2020.1735615.
［80］	Hu M, Liao K, Lei W, et al. The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo: a systematic review and meta⁃analysis［J］. Int Immunopharmacol, 2021,98:107910. doi: 10.1016/j.intimp.2021. 107910.
［81］	Liu X, Yao Z, Wang Y, et al. Vitamin D analogs combined with different types of phototherapy in the treatment of vitiligo: a systematic review of randomized trials and within⁃patient studies［J］. Int Immunopharmacol, 2022,109:108789. doi: 10.1016/j.intimp.2022.108789.
［82］	Juntongjin P, Sangganjanavanich P. Efficacy of the combined excimer light and topical calcipotriol for acral vitiligo: a randomized double⁃blind comparative study［J］. Dermatol Ther, 2021,34（2）:e14886. doi: 10.1111/dth.14886.
［83］	Arora CJ, Rafiq M, Shumack S, et al. The efficacy and safety of tacrolimus as mono⁃ and adjunctive therapy for vitiligo: a systematic review of randomised clinical trials［J］. Australas J Dermatol, 2020,61（1）:e1⁃e9. doi: 10.1111/ajd.13096.
［84］	Bae JM, Hong BY, Lee JH, et al. The efficacy of 308⁃nm excimer laser/light （EL） and topical agent combination therapy versus EL monotherapy for vitiligo: a systematic review and meta⁃analysis of randomized controlled trials （RCTs）［J］. J Am Acad Dermatol, 2016,74（5）:907⁃915. doi: 10.1016/j.jaad.2015.11.044.
［85］	Dang YP, Li Q, Shi F, et al. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta⁃analysis［J］. Dermatol Ther, 2016,29（2）:126⁃133. doi: 10.1111/dth.12295.
［86］	Lee JH, Kwon HS, Jung HM, et al. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2019,155（8）:929⁃938. doi: 10.1001/jamadermatol.2019.0696.
［87］	Ju HJ, Han JH, Kim MS, et al. The long⁃term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo［J］. J Am Acad Dermatol, 2021,84（6）:1619⁃1627. doi: 10.1016/j.jaad.2021.01.067.
［88］	Nordal EJ, Guleng GE, Rönnevig JR. Treatment of vitiligo with narrowband⁃UVB （TL01） combined with tacrolimus ointment （0.1%） vs. placebo ointment, a randomized right/left double⁃blind comparative study［J］. J Eur Acad Dermatol Venereol, 2011,25（12）:1440⁃1443. doi: 10.1111/j.1468⁃3083.2011.04002.x.
［89］	Zhang DM, Hong WS, Fu LF, et al. A randomized controlled study of the effects of different modalities of narrow⁃band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo［J］. Dermatol Surg, 2014,40（4）:420⁃426. doi: 10.1111/dsu.12444.
［90］	王美玲, 王保强, 刘华绪. CO2点阵激光联合308 nm准分子激光治疗白癜风疗效和安全性meta分析［J］. 中国麻风皮肤病杂志, 2021,37（1）:13⁃18.
［91］	Kim WI, Kim S, Lee SH, et al. The efficacy of fractional carbon dioxide laser combined with narrow⁃band ultraviolet B phototherapy for non⁃segmental vitiligo: a systematic review and meta⁃analysis［J］. Lasers Med Sci, 2021,36（1）:165⁃173. doi: 10.1007/s10103⁃020⁃03069⁃0.
［92］	Chang HC, Lin MH, Tsai HH. Efficacy of combination therapy with fractional carbon dioxide laser and ultraviolet B phototherapy for vitiligo: a systematic review and meta⁃analysis［J］. Aesthet Surg J, 2020,40（1）:NP46⁃NP50. doi: 10.1093/asj/sjz250.
［93］	Esmat S, Assaf MI, Mohye Eldeen R, et al. Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study［J］. J Dermatolog Treat, 2022,33（5）:2621⁃2628. doi: 10.1080/09546634.2022.2062279.
［94］	Chu GY, Weng SM, Huang CC, et al. Surrounding needling and narrowband ultraviolet B phototherapy treatment: synergistic effects for repigmentation in chronic, stable nonsegmental vitiligo［J］. Altern Ther Health Med, 2023,29（1）:96⁃103.
［95］	Jung HM, Jung YS, Lee JH, et al. Antioxidant supplements in combination with phototherapy for vitiligo: a systematic review and metaanalysis of randomized controlled trials［J］. J Am Acad Dermatol, 2021,85（2）:506⁃508. doi: 10.1016/j.jaad.2018.10.010.
［96］	Middelkamp⁃Hup MA, Bos JD, Rius⁃Diaz F, et al. Treatment of vitiligo vulgaris with narrow⁃band UVB and oral polypodium leucotomos extract: a randomized double⁃blind placebo⁃controlled study［J］. J Eur Acad Dermatol Venereol, 2007,21（7）:942⁃950. doi: 10.1111/j.1468⁃3083.2006.02132.x.
［97］	Fontas E, Montaudié H, Passeron T. Oral gliadin⁃protected superoxide dismutase in addition to phototherapy for treating non⁃segmental vitiligo: a 24⁃week prospective randomized placebo⁃controlled study［J］. J Eur Acad Dermatol Venereol, 2021,35（8）:1725⁃1729. doi: 10.1111/jdv.17331.
［98］	Dell'Anna ML, Mastrofrancesco A, Sala R, et al. Antioxidants and narrow band⁃UVB in the treatment of vitiligo: a double⁃blind placebo controlled trial［J］. Clin Exp Dermatol, 2007,32（6）:631⁃636. doi: 10.1111/j.1365⁃2230.2007.02514.x.
［99］	Sun Y, Guan X, Wang H, et al. Randomized clinical trial of combined therapy with oral α⁃lipoic acid and NB⁃UVB for nonsegmental stable vitiligo［J］. Dermatol Ther, 2021,34（1）:e14610. doi: 10.1111/dth.14610.
［100］	Yones SS, Palmer RA, Garibaldinos TM, et al. Randomized double⁃blind trial of treatment of vitiligo: efficacy of psoralen⁃UV⁃A therapy vs narrowband⁃UV⁃B therapy［J］. Arch Dermatol, 2007,143（5）:578⁃584. doi: 10.1001/archderm.143.5.578.
［101］	Bhatnagar A, Kanwar AJ, Parsad D, et al. Comparison of systemic PUVA and NB⁃UVB in the treatment of vitiligo: an open prospective study［J］. J Eur Acad Dermatol Venereol, 2007,21（5）:638⁃642. doi: 10.1111/j.1468⁃3083.2006.02035.x.
［102］	Dincer Rota D, Aksoy Sarac G, Arca E, et al. Comparison of the efficacy of broad⁃band targeted UVB phototherapy and topical psoralen with targeted UVA phototherapy in localized vitiligo［J］. Dermatol Ther, 2021,34（1）:e14562. doi: 10.1111/dth. 14562.
［103］	Halpern SM, Anstey AV, Dawe RS, et al. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group［J］. Br J Dermatol, 2000,142（1）:22⁃31. doi: 10.1046/j.1365⁃2133.2000.03237.x.
［104］	Esmat S, Hegazy RA, Shalaby S, et al. Phototherapy and combination therapies for vitiligo［J］. Dermatol Clin, 2017,35（2）:171⁃192. doi: 10.1016/j.det.2016.11.008.
［105］	Shenoi SD, Prabhu S, Indian Association of Dermatologists VaL, et al. Photochemotherapy （PUVA） in psoriasis and vitiligo［J］. Indian J Dermatol Venereol Leprol, 2014,80（6）:497⁃504. doi: 10.4103/0378⁃6323.144143.
［106］	El⁃Zawahry BM, Bassiouny DA, Sobhi RM, et al. A comparative study on efficacy of UVA1 vs. narrow⁃band UVB phototherapy in the treatment of vitiligo［J］. Photodermatol Photoimmunol Photomed, 2012,28（2）:84⁃90. doi: 10.1111/j.1600⁃0781.2011. 00643.x.
［107］	El⁃Zawahry BM, Elmasry MF, Ragab A. The role of long⁃wavelength ultraviolet A1 （UVA1） in acral vitiligo［J］. J Cosmet Dermatol, 2019,18（4）:1155⁃1160. doi: 10.1111/jocd. 12808.
［108］	Lotti T, Tchernev G, Wollina U, et al. Successful treatment with UVA 1 laser of non ⁃ responder vitiligo patients［J］. Open Access Maced J Med Sci, 2018,6（1）:43⁃45. doi: 10.3889/oamjms.2018.047.
［109］	Babino G, Giunta A, Esposito M, et al. UVA1 laser in the treatment of vitiligo［J］. Photomed Laser Surg, 2016,34（5）:200⁃204. doi: 10.1089/pho.2015.4004.
［110］	Zubair R, Hamzavi IH. Phototherapy for vitiligo［J］. Dermatol Clin, 2020,38（1）:55⁃62. doi: 10.1016/j.det.2019.08.005.
［111］	Barros NM, Sbroglio LL, Buffara MO, et al. Phototherapy［J］. An Bras Dermatol, 2021,96（4）:397⁃407. doi: 10.1016/j.abd. 2021.03.001.
［112］	Bae JM, Ju HJ, Lee RW, et al. Evaluation for skin cancer and precancer in patients with vitiligo treated with long⁃term narrowband UV⁃B phototherapy［J］. JAMA Dermatol, 2020,156（5）:529⁃537. doi: 10.1001/jamadermatol.2020.0218.
［113］	Perna JJ, Mannix ML, Rooney JF, et al. Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model［J］. J Am Acad Dermatol, 1987,17（3）:473⁃478. doi: 10.1016/s0190⁃9622（87）70232⁃1.
［114］	Bae JM, Eun SH, Oh SH, et al. The 308⁃nm excimer laser treatment does not increase the risk of skin cancer in patients with vitiligo: a population⁃based retrospective cohort study［J］. Pigment Cell Melanoma Res, 2019,32（5）:714⁃718. doi: 10. 1111/pcmr.12781.

[1]	Yuan Yongyong, Pan Meng. Advances in Hailey-Hailey Disease [J]. Chinese Journal of Dermatology, 2025, 0(3): 20240182-e20240182.
[2]	Song Pu, Liu Yu, Guo Sen, Li Shuli, Liu Ling, Li Chunying. Mast cell-derived chemokine C-C motif ligand 5 affects the migration of CD8⁺ T cells in vitiligo under oxidative stress [J]. Chinese Journal of Dermatology, 2025, 0(2): 20230513-e20230513.
[3]	Zhou Miaoni, Sheng Anqi, Fu Lifang, Jin Rong, Xu Wen, Wei Xiaodong, Xu Ai′e . Efficacy and safety of tea polyphenol antioxidant gel combined with narrow-band ultraviolet B in the treatment of vitiligo: a single-center randomized controlled trial [J]. Chinese Journal of Dermatology, 2025, 0(2): 20240421-e20240421.
[4]	Li Qianwen, Liao Zhikai, Le Yue, Duan Bolin, Geng Mengmeng, Lei Tiechi. The antioxidant Tempol inhibits pigment loss in tail skin of a mouse model of immune-induced vitiligo under oxidative stress [J]. Chinese Journal of Dermatology, 2025, 58(2): 126-131.
[5]	Wang Di, Zhang Ruijun, Kang Yuying. Pathogenesis and treatment of seborrheic dermatitis [J]. Chinese Journal of Dermatology, 2025, 58(1): 89-92.
[6]	Luo Li, Zhang Bona, Wu Wei, Tang Wenjing, Li Yuehua, Liu Xiaoli, Ma Yanan, Li Cuicui, Qi Mengyan, Sun Ni, Shi Qiong. Efficacy and safety of 308-nm excimer laser and 308-nm excimer lamp in the treatment of 194 children with vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(8): 721-727.
[7]	Chen Jiaxi, Yi Xiuli, Li Chunying, Li Shuli. Study on the protective effect of folic acid against oxidative stress-induced damage to melanocytes in vitro [J]. Chinese Journal of Dermatology, 2024, 57(6): 547-552.
[8]	aser Cosmetology Group, Medical Aesthetics and Cosmetology Branch of Chinese Medical Association, Skin Care Product and Material Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment, Laser Group, Cosmetic and Plastic Surgeon Branch of Chinese Medical Doctor Association, Cosmetic Laser Group, Chinese Society of Dermatology. Guidelines for the diagnosis and treatment of adverse skin reactions to cosmetics （2024 edition） [J]. Chinese Journal of Dermatology, 2024, 57(6): 485-492.
[9]	China Dermatologist Association. Guidelines for the management of chronic pruritus （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 387-399.
[10]	Zhang Dimin, Cao Cheng, Zhou Miaoni, Sheng Anqi, Lin Fuquan, Xu Ai′e. Analysis of disease control rate and its influencing factors in patients with progressive non-segmental vitiligo after combined treatment with compound betamethasone injection [J]. Chinese Journal of Dermatology, 2024, 57(4): 350-354.
[11]	Chinese Society of Dermatology, National Center for STD Control, Chinese Center for Disease Control and Prevention, China Dermatologist Association, Chinese Association Rehabilitation of Dermatology. Guideline for the diagnosis and treatment of Chlamydia trachomatis urogenital infection in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(3): 193-200.
[12]	Dai Yeqin, Song Xiuzu. Application of hair follicle transplantation and follicular cell suspension transplantation in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230274-e0230274.
[13]	Liu Lyuye, Zhang Junling. Ferroptosis in common skin diseases [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220783-e20220783.
[14]	Zhang Yude, Wang Hongjuan, Kang Xiaojing. Stem cell therapy for vitiligo: advances in basic and clinical research [J]. Chinese Journal of Dermatology, 2024, 0(3): 20240127-e20240127.
[15]	Mycobacteriosis Research Group, China " Belt and Road " Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the diagnosis and treatment of cutaneous nontuberculous mycobacterial diseases in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(2): 109-118.

Guideline on phototherapy for vitiligo （2025 edition）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［114］

Related Articles 15

Metrics

Comments

Recommended 10